nach oben

Erschienen in:

18.12.2020 | Correction

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study

verfasst von: Janet H. Ford, Virginia L. Stauffer, Peter McAllister, Sreelatha Akkala, Matthew Sexson, David W. Ayer, Shufang Wang

Erschienen in: Quality of Life Research | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Excerpt

In the original publication, Fig. 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days. …

Titel: Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
verfasst von: Janet H. Ford
Virginia L. Stauffer
Peter McAllister
Sreelatha Akkala
Matthew Sexson
David W. Ayer
Shufang Wang
Publikationsdatum: 18.12.2020
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 2/2021
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02720-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Development and assessment of a verbal response scale for the Patient-Specific Functional Scale (PSFS) in a low-literacy, non-western population

The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials

Quality of life more than 10 years after radiotherapy for localized prostate cancer—impact of time after treatment and prescription dose

A multi-center psychometric evaluation of the Severity Indices of Personality Problems 118 (SIPP-118): Do we really need all those facets?

Loneliness in adolescence: a Rasch analysis of the Perth A-loneness scale

A non-compensatory analysis of quality of life in breast cancer survivors using multivariate hidden Markov modeling